Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
OmniSpirant Limited logo — Changing the paradigm of treatment for cancer and respirator...

OmniSpirant Limited

Changing the paradigm of treatment for cancer and respiratory disease.

Founded 2016 Ireland Ireland 7 employees Grant Total: $71.43K Biotechnology

General Information

Company Name OmniSpirant Limited
Founded Year 2016
Location Ireland Ireland +1
Employees 7
Industries Biotechnology
Funding Stage Grant
Social

Get notified when OmniSpirant Limited moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About OmniSpirant Limited

OmniSpirant is an early stage therapeutics company based in Ireland founded in 2016. The company is on a mission to change the paradigm of treatment for cancer and respiratory diseases through its innovative inhaled stem cell exosomes platform technology. OmniSpirant's proprietary technologies, which encompass the synergistic potential of regenerative medicine and gene therapy, have the potential to revolutionize treatment for millions of patients. The company recently secured a €71.43K grant investment on 01 January 2019, with the funding provided by EASME - EU Executive Agency for SMEs. With its focus on the biotechnology industry, OmniSpirant holds promise for transforming the landscape of medical treatments for cancer and respiratory diseases.

Taxonomy: Therapeutics company, Ireland, Novel platform technology, Inhaled stem cell exosomes, Cancer treatment, Respiratory disease treatment, Regenerative medicine, Gene therapy, Regenerative gene therapies, Early stage, Game-changing treatments, Respiratory medicine, Regenerative medicine, Healthcare innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 01 Jan 2019

OmniSpirant Limited Alternatives & Competitors

OmniSpirant Limited vs
Genascence Corporation
Genascence Corporation

Clinical-stage biotechnology company developing life-changing gene therapy products for musculoskele...

Grant
7 employees
Biotechnology
OmniSpirant Limited vs
Remedium Bio
Remedium Bio United States

We believe that any disease can be cured

Grant
17 employees
Biotechnology, Health Care
OmniSpirant Limited vs
Ligandal
Ligandal United States

Ligandal is developing precision molecular therapeutics and targeted delivery technologies.

Seed
12 employees
Biotechnology

FAQ About OmniSpirant Limited

Changing the paradigm of treatment for cancer and respiratory disease.
OmniSpirant Limited was founded in 2016.
OmniSpirant Limited is headquartered in Ireland.
OmniSpirant Limited operates in the following industries: Biotechnology.
OmniSpirant Limited has approximately 7 employees.
OmniSpirant Limited has completed 1 funding round, raising a total of $71.43K. The latest funding stage is Grant.
Top alternatives and competitors to OmniSpirant Limited include Genascence Corporation, Remedium Bio, Ligandal, LambdaGen Pte. Ltd. , AlveoGene. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
OmniSpirant Limited and Genascence Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors OmniSpirant Limited and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy